What is Kura Oncology's debt-to-assets?

Kura Oncology (KURA) reported debt-to-assets of 0× in Q1 2026.

How has Kura Oncology's debt-to-assets changed year-over-year?

Kura Oncology's debt-to-assets increased by 43.1% year-over-year, from 0× to 0×.

What is the long-term trend for Kura Oncology's debt-to-assets?

Over 5 years (2020 to 2025), Kura Oncology's debt-to-assets has grown at a 3.7% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Kura Oncology KURA Debt-to-assets

Debt-to-assets at other companies

Johnson & JohnsonJNJ

0.3×0.0×

AmgenAMGN

0.6×0.0×

ExelixisEXEL

0.1×0.0×

Syndax PharmaceuticalsSNDX

0.7×+0.2×

AbbVieABBV

0.5×0.0×

Corvus PharmaceuticalsCRVS

0×0.0×

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+81.6%

Enterprise value$927.97M+90.7%

P/S13.2×+3.6×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's debt-to-assets?: Kura Oncology (KURA) reported debt-to-assets of 0× in Q1 2026.
How has Kura Oncology's debt-to-assets changed year-over-year?: Kura Oncology's debt-to-assets increased by 43.1% year-over-year, from 0× to 0×.
What is the long-term trend for Kura Oncology's debt-to-assets?: Over 5 years (2020 to 2025), Kura Oncology's debt-to-assets has grown at a 3.7% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.